Bayer, MSD and Takeda among winners at Asia Pacific awards

Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations that have pushed boundaries in patient care, leaving a lasting impact on their local communities.

Among the standout accomplishments at the Healthcare Asia Pharma Awards, Bayer Singapore claimed top honours for both the Digital Innovation of the Year and the Marketing & Communications Initiative of the Year categories. Their Bayer For Her campaign captured hearts and minds, igniting a crucial conversation about women’s health across Asia.

At the core of the campaign lies a simple yet powerful concept: providing a safe space for women to voice their health concerns. Through a user-friendly QR code interface, women can seamlessly connect with local healthcare professionals who offer tailored guidance and support. Initially launched in Thailand in September 2022, Bayer For Her has rapidly expanded its footprint, now spanning nine Asian countries and collaborating with 18 local partners and non-governmental organizations.

The campaign’s success is underscored by its multifaceted approach, leveraging strategic partnerships and innovative tactics to reach diverse audiences. From educational events and pharmacy collaborations to pop-up clinics and digital outreach efforts, Bayer left no stone unturned in its mission to empower women and promote health awareness.

Notably, the campaign’s digital activation on social media platforms like Instagram, Meta, TikTok, and KakaoTalk resonated deeply, garnered 692 million impressions. Additionally, Bayer’s commitment to community engagement shines through the campaign’s mobilisation of employees and healthcare professionals, with the latter providing free consultations in some markets.

Other industry leaders including MSD, Takeda, Alcon and Cipla were also recognised for their exemplary efforts. MSD Australia and MSD Singapore clinched awards for their outstanding Marketing & Communications Initiative and Patient Advocacy Program, respectively. Meanwhile, Takeda emerged victorious in several categories across its Singapore, Thailand and Taiwan affiliates.

In reimagining healthcare across the entire patient journey, Health Industry Hub^TM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.